|
XPO7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.653400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.343000E-01 |
| Normal-vs-Stage2 |
2.468200E-01 |
| Normal-vs-Stage3 |
3.611000E-01 |
| Normal-vs-Stage4 |
6.233600E-01 |
| Stage1-vs-Stage2 |
2.212600E-01 |
| Stage1-vs-Stage3 |
2.835200E-01 |
| Stage1-vs-Stage4 |
6.083000E-01 |
| Stage2-vs-Stage3 |
6.604800E-01 |
| Stage2-vs-Stage4 |
4.678000E-01 |
| Stage3-vs-Stage4 |
6.984800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.231600E-01 |
| Normal-vs-AfricanAmerican |
1.257990E-01 |
| Normal-vs-Asian |
7.726000E-01 |
| Caucasian-vs-AfricanAmerican |
4.068000E-02 |
| Caucasian-vs-Asian |
4.281000E-01 |
| AfricanAmerican-vs-Asian |
2.141400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.102400E-01 |
| Normal-vs-Female |
7.873200E-01 |
| Male-vs-Female |
4.454400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.833600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.191400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.736200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.145830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.028200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.053440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.401600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.847400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.692400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.358000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.673370E-01 |
| Classical-VS-Follicular |
1.382030E-04 |
| Classical-VS-Other |
3.538800E-01 |
| Classical-VS-Normal |
5.093600E-01 |
| Tall-VS-Follicular |
3.052600E-01 |
| Tall-VS-Other |
8.178000E-01 |
| Tall-VS-Normal |
4.290000E-01 |
| Follicular-VS-Other |
7.370000E-01 |
| Follicular-VS-Normal |
3.559800E-02 |
| Other-VS-Normal |
5.038200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.547000E-01 |
| Normal-vs-N1 |
4.040800E-01 |
| N0-vs-N1 |
9.553000E-01 |
|
|
